Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT04859543
NA

Pediatric Prospective Personalized Immune and Target Identification Trial

Sponsor: Masaryk University

View on ClinicalTrials.gov

Summary

PPROSPERITIT is a prospective clinical study assessing the use of comprehensive molecular profiling to define the best matching targeted and immune treatment for relapsed, refractory or very high risk pediatric CNS tumors.

Official title: Prospective, Interventional Diagnostic, Multicenter, Non-treatment Clinical Study Identifying Specific Molecular Changes by Using Genomic Sequencing Technologies in Refractory/Recurrent or Very High-risk Pediatric CNS Tumors.

Key Details

Gender

All

Age Range

1 Year - 19 Years

Study Type

INTERVENTIONAL

Enrollment

80

Start Date

2021-02-02

Completion Date

2024-12-10

Last Updated

2026-05-01

Healthy Volunteers

No

Interventions

DEVICE

FoundationOneHeme

Tumor tissue obtained during standard surgery will be subsequently examined histopathologically and the content of cancer cells will be determined. Broad molecular profiling of the tumor; with potential results finding such molecular changes, for which the specific targeted anti-tumor treatment will be performed.

Locations (3)

Medical University of Vienna

Vienna, Spitalgasse 23,, Austria

Motol University Hospital

Prague, V Úvalu 84,, Czechia

University Hospital Brno

Brno, Černopolní 9,, Czechia